SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Therapeutics (CTIC)
CTIC 9.0900.0%Jun 26 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: zeta1961 who wrote (565)3/7/2005 8:27:54 PM
From: Sam Citron  Read Replies (1) of 946
 
Zeta,

I didn't mean to interrupt your conversation with former_pgs, but was interested in what you had to say about this frequent side-effect of cancer treatment. I know very little about alopecia, but am sure it something that a cancer patient must feel very deeply as a sign of loss of the patient's healthy self. In a younger patient (probably not relavent to Stellar 3 population) it must be particularly devastating. Economists tend to be obsessed with quantification: e.g., is it treatable and if so how much is spent to treat it; how much is spent on wigs to disguise it, etc. I know it is impossible to quantify everything, but also know that only by trying to do so can we get even vaguely accurately cost-benefit analysis that is so important in the public policy arena. Your use of the "dealbreaker" word surprised me, and I was just hoping that you could educate me a bit on it. Perhaps it is one of the key factors that needs to be better understood to appreciate the value of Xyotax.

BTW, is alopecia the result of the radiation treatments or the drugs used in conjunction with them? [shows how little I know]

Sam
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext